Table 2. Characteristics of Paris Prospective Study III study participants by cardiovascular health status.
| Variables | Poor (40.38%) | Intermediate (49.52%) | Ideal (10.10%) | p-value* |
|---|---|---|---|---|
| Age | 59.5 (±6.13) | 59.7 (±6.40) | 59.27(±6.32) | 0.14 |
| Men | 2715 (71.4%) | 2641 (56.6%) | 403 (42.3%) | <0.001 |
| University education | 2514 (66.7%) | 3257 (72.8%) | 688 (72.8%) | 0.01 |
| Self Rated Health | 7.24 (±1.74) | 7.51 (±1.69) | 7.64 (±1.76) | <0.001 |
| Living Alone | 896 (23.6%) | 1260 (27.1%) | 289 (30.5%) | <0.001 |
| Body Mass Index | 27.3 (±3.50) | 24.1 (±3.19) | 22.22 (±2.35) | <0.001 |
| Smoking Ideal | 2638 (69.40%) | 4084 (87.6%) | 917 (96.4%) | <0.001 |
| Physical ActivityIdeal | 1039 (27.5%) | 2725 (58.7%) | 808 (85.01%) | <0.001 |
| Fruits and VegetablesIdeal | 1064 (29.5%) | 1817 (41.9%) | 491 (57.2%) | <0.001 |
| FishIdeal | 1400 (38.5%) | 1903 (43.6%) | 476 (55%) | <0.001 |
| SugarIdeal | 2000 (55.3%) | 2534 (58.3%) | 582 (67.4%) | <0.001 |
| SodiumIdeal | 1100 (30.8%) | 1552 (36.4%) | 459 (53.8%) | <0.001 |
| Fasting Total Cholesterol mg/dl | 228.3 (±35.85) | 219 (±35.5) | 204 (±35.22) | <0.001 |
| Systolic Blood Pressure mmHg | 136 (±15) | 130 (±16) | 118 (±13.8) | <0.001 |
| Fasting Serum Glucose mg/dl | 106 (±16.3) | 97.6 (±12) | 92.8 (±6.16) | <0.001 |
| Personal history of CVD† | 122 (3.22%) | 119 (2.58%) | 0 (0%) | <0.001 |
| Treatment for blood pressure | 731 (19.2%) | 534 (11.5%) | 34 (3.58%) | <0.001 |
| Treatment for lipids | 690 (18.3%) | 475 (10.2%) | 40 (4.21%) | <0.001 |
Data are reported as n (%) and mean (+/− standard deviation) for categorical and continuous variables respectively.
Poor, intermediate and ideal CVH are defined as having 0–2, 3–4 and 5–7 health metrics at the ideal level, respectively.
*p-value for a chi-squared test for trend or ANOVA were appropriate.
†CVD: Cardiovascular disease.